All news from Ophthalmology

ASN: High-dose, Proactive IV Iron Noninferior in Hemodialysis

For patients undergoing maintenance hemodialysis, a high-dose intravenous iron regimen administered proactively is noninferior to a low-dose intravenous iron regimen administered reactively, according to a study published online Oct. 26 in the New England Journal of Medicine to coincide with a presentation at the American Society of Nephrology's Kidney Week, held Oct. 23 to 28 in San Diego

Hearing Loss Patients At Risk Of Hospitalization

Researchers at New York University in New York City examined data from a nationally representative survey and found that discharged hospital patients who reported trouble communicating with their doctors had 32% greater odds of hospital readmission in the next month.

Hard-of-hearing hospital patients who have trouble communicating with medical personnel are more likely to end up back in the hospital within 30 days, compared to patients who don’t have trouble hearing.

The study was published in JAMA Otolaryngology-Head & Neck Surgery.

High-Performance Instruments & analytical, Diagnostic Solutions At Molecular level

At the 2018 Annual Meeting of the Society for Neuroscience, Bruker today announced the release of the Ultima 2Pplus next-generation multiphoton, all-optical stimulation and simultaneous imaging platform for neurobiology applications.

The Ultima 2Pplus features the best commercially available combination of advanced photostimulation experiments, including holographic stimulation, combined with simultaneous wide-field, enhanced-sensitivity imaging. In addition, the new Ultima 2Pplus anticipates future techniques by offering longer wavelength 3-photon imaging (up to 1700 nm) for looking deep into living tissue.